Immuno-Oncology Capabilities

An overview of Synexa’s capabilities in the immuno-oncology space.

May 31, 2021

Biosimilar Research and Development Expertise

Synexa provides PK and ADA solutions for biosimilars according to a sponsor’s priorities and requirements.

March 23, 2021

COVID-19 Serology Testing

Synexa’s validated assay detects IgG, IgM, IgA and SARS-CoV-2 nAbs.

March 23, 2021

News Signup

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Talk to our Biomarker Experts